7 December 2020 - Medicines which can be used to treat a form of blood cancer and a rare muscle disorder have today been accepted by the Scottish Medicines Consortium for use by NHSScotland.

Venetoclax (Venclyxto) was accepted for the treatment of certain patients with previously untreated chronic lymphocytic leukaemia.

Read SMC press release